Mindful Walking in Low Back Pain (MW-LBP)

This study has been completed.
Information provided by (Responsible Party):
Benno Brinkhaus, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
First received: July 2, 2013
Last updated: March 25, 2014
Last verified: March 2014

The purpose of this study is to determine whether a mindful walking program is effective in the treatment of patients with chronic low back pain.

Condition Intervention
Chronic Low Back Pain
Behavioral: Mindful walking program

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness of a a Mindful Walking Program in Patients With Chronic Low Back Pain - a Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Pain intensity on visual analogue scale [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Back function - FFbH-R-Questionnaire [ Time Frame: 8 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Pain intensity on visual analogue scale [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
  • Cohens perceived stress scale [ Time Frame: 8 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Quality of Life - SF 36 [ Time Frame: 8 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Intake of paracetamol [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Adverse events [ Time Frame: 8 weeks, 12 weeks ] [ Designated as safety issue: Yes ]

Enrollment: 48
Study Start Date: June 2013
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Mindful walking
A weekly 60 minutes walking group exercise program consisting of a combination of walking and mindfulness over 8 weeks.
Behavioral: Mindful walking program
No Intervention: Waiting group


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • male and female, 18-65 years
  • chronic low back pain (disease duration > 3 months)
  • pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • undersigned informed consent form

Exclusion Criteria:

  • active walking or jogging in the last 6 weeks (< 60 minutes/week)
  • regular meditation, relaxation exercise, mindfulness exercise in last 6 weeks (> 30 minutes per week)
  • use of complementary medicine therapies as acupuncture, homeopathy, herbal medicine in last 6 weeks or planned in the next 12 weeks
  • use of other nonpharmacological therapies as physical therapy, manual therapy or osteopathy in the last 4 weeks
  • participation in another trials within the last 3 months
  • pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • risk of falls and inability to walk
  • angina pectoris in the last 3 months
  • chronic respiratory disease with respiratory insufficiency
  • intake of central nervous system-acting analgesics in the last 6 weeks
  • Known renal and / or hepatic diseases
  • Severe organic, psychological or psychiatric disorders that are not permitting a study participation
  • applying for early retirement due to low back pain
  • no undersigned informed consent form
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01893073

Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Germany
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Benno Brinkhaus, Professor, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01893073     History of Changes
Other Study ID Numbers: MW-LBP
Study First Received: July 2, 2013
Last Updated: March 25, 2014
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on April 17, 2014